Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$108.18 USD
-0.51 (-0.47%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $108.25 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$108.18 USD
-0.51 (-0.47%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $108.25 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
Zacks News
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical
by Zacks Equity Research
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche
by Zacks Equity Research
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche
MedTech Sails Through Macro Woes: Stocks in Focus
by Zacks Equity Research
Mergers & acquisitions, emerging market expansion, positive demographic trends and new product innovation are the vital forces behind the continued uptrend in the sector's performance.
MedTech Industry Stock Outlook - December 2016
by Zacks Equity Research
The Republican win marked a great victory for the entire medical device industry as the likelihood of a permanent repeal of the 2.3% medical device excise tax will come as a big bonus.
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
3 MedTech Stocks Poised to Trump Earnings in Q3
by Zacks Equity Research
Positive demographic trends, new product cycles, expansion into emerging markets and widespread consolidation are the key traits for the MedTech sector.
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
MedTech M&As Continue Regardless of Tax Scenarios
by Zacks Equity Research
MedTech stalwarts are not expected to shy away from hostile acquisition bids this year.